In particular, Nikitin and colleagues showed that activation of the ATM/Chk2 signaling pathway after in vitro EBV infection of B-cells is critical for the suppression of EBV-mediated B-cell transformation and can act as an innate tumor suppression pathway [11]. This evidence concerns the gene CHEK2 and Epstein-Barr virus infection.